How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,985 results for

E/M Established Outpatient Visit


Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Management of Infertility

. Suggested citation: Myers ER, Eaton JL, McElligott KA, Moorman PG, Chatterjee R, Zakama AK, Goldstein K, Strauss J, Coeytaux RR, Goode A, Borre E, Swamy GK, McBroom AJ, Lallinger K, Schmidt R, Davis JK, Hasselblad V, Sanders GD. Management of Infertility. Comparative Effectiveness Review No. 217. (Prepared by the Duke Evidence-based Practice Center under Contract No. 290-2015-00004-I.) AHRQ Publication No. 19-EHC014-EF. Rockville, MD: Agency for Healthcare Research and Quality; May 2019. Posted final (...) EPC systematic reviews, see AHRQ expects that these systematic reviews will be helpful to health plans, providers, purchasers, government programs, and the healthcare system as a whole. Transparency and stakeholder input are essential to the Effective Health Care Program. Please visit the website ( to see draft research questions and reports or to join an email list to learn about new program products

2019 Effective Health Care Program (AHRQ)

122. Prevention and early intervention for adults with mild to moderate depression Phone: +61 2 91889500 Suggested Citation: Kay-Lambkin F, Gilbert J, Pedemont L, Sunderland M, Dalton H et al. Prevention and early intervention for people aged 18 and over with, or at risk of, mild to moderate depression and anxiety: An Evidence Check rapid review brokered by the Sax Institute ( for Beyond Blue, 2018. Disclaimer: This Evidence Check Review was produced using the Evidence Check methodology in response to specific questions from the commissioning agency (...) for the depression RCTs (mild–moderate range) but confirmed the well-established finding across the treatment and epidemiological literature that comorbidity between depression and anxiety is high. Of interest is that the effects of cognitive behaviour therapy on anxiety extended to significant reductions in depressive symptoms, despite depression not being specifically targeted in the anxiety interventions. These effects were moderate to large, indicating a direct effect of anxiety treatments on mild–moderate

2018 Sax Institute Evidence Check

123. Programs and services for suicide prevention

to the inclusions of an acknowledgement of the source. It may not be reproduced for commercial usage or sale. Reproduction for purposes other than those indicated above requires written permission from the copyright owners. Enquiries regarding this report may be directed to the: Principal Analyst Knowledge Exchange Program Sax Institute Phone: +61 2 91889500 Suggested Citation: Maple M, Wayland S, Pearce T, Hua P. Services and programs for suicide (...) -based health care and are published online in the Cochrane Library. Comorbidity The presence of one or more additional diseases or disorders that co-occur with a primary disease or disorder Digitally-enhanced programs In this report this term refers to use of technology (apps, online platforms, connecting with people via the internet) as well as upscaling programs from face to face connection, to ongoing connection via a digital platform. E-health interventions Interventions delivered via an online

2018 Sax Institute Evidence Check

124. Addressing Social Isolation To Improve the Health of Older Adults: A Rapid Review

:// b Hartling L, Guise JM, Kato E, et al. EPC Methods: An Exploration of Methods and Context for the Production of Rapid Reviews. Rockville (MD): 2015. c Hartling L, Guise J-M, Hempel S, et al. Fit for purpose: perspectives on rapid reviews from end-user interviews. Systematic Reviews. 2017;6:32. doi: 10.1186/s13643-017-0425-7. PMID: PMC5316162. v Gopal Khanna, M.B.A. Director Agency for Healthcare Research and Quality Stephanie Chang (...) in this report. For assistance contact Suggested citation: Veazie S, Gilbert J, Winchell K, Paynter R, Guise J-M. Addressing Social Isolation To Improve the Health of Older Adults: A Rapid Review. Rapid Evidence Product. (Prepared by Scientific Resource Center under Contract No. 290-2017-00003-C.) AHRQ Publication No. 19-EHC009-EF. Rockville, MD: Agency for Healthcare Research and Quality; February 2019. Posted final reports are located on the Effective Health Care Program search page. DOI

2019 Effective Health Care Program (AHRQ)

125. Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions: A Workshop Report

with COPD with strong ties to primary care, instituted a COPD community care manager to help patients navigate between inpatient and outpatient settings. The care manager interacts directly with the patient and family, documents the care plan, including a customized education assessment, facilitates referrals to PR care, and makes home visits to the patients 2–3 days after discharge. The introduction of the care manager was associated with a 1-year decline in readmissions after a COPD exacerbation from (...) to provide proactive, pulmonologist-facilitated, electronic consults (E-consults) for patients discharged after a hospitalization for an exacerbation of COPD. E-consult recommendations are recorded in chart notes and orders written for PCPs to sign, discontinue, or change as needed; these are timed to occur just before the patient’s follow-up visit when changes in care can be discussed. PCP autonomy, therefore, is maintained and the intervention minimally disrupts clinic workflow. If effective, E

2019 American Thoracic Society

126. Measurement of Blood Pressure in Humans

: A Scientific Statement From the American Heart Association , PhD, MHS, FAHA, Chair , MD, Vice Chair , MD, FAHA , PhD , PhD , MD, FAHA , MD , MD, FAHA , PhD , MD, FAHA , MD, MS, FAHA , MD, MPH, FAHA , MD, FAHA , MD, PhD, FAHA Paul Muntner , Daichi Shimbo , Robert M. Carey , Jeanne B. Charleston , Trudy Gaillard , Sanjay Misra , Martin G. Myers , Gbenga Ogedegbe , Joseph E. Schwartz , Raymond R. Townsend , Elaine M. Urbina , Anthony J. Viera , William B. White , Jackson T. Wright Jr , Originally published 1 (...) healthcare visits, herein referred to as office BP . Before the 21st century, office BP was measured by an observer listening to sounds with a stethoscope while watching a sphygmomanometer (ie, auscultation). However, semiautomated and automated devices that use the oscillometry method, which detects the amplitude of the BP oscillations on the arterial wall, have become widely used over the past 2 decades. In addition, substantial data have accumulated demonstrating that BP is different for many people

2019 American Heart Association

127. Home Oxygen Therapy for Children

x Don Hayes, Jr. , x Kevin C. Wilson , x Katelyn Krivchenia , x Stephen M. M. Hawkins , x Ian M. Balfour-Lynn , x David Gozal , x Howard B. Panitch , x Mark L. Splaingard , x Lawrence M. Rhein , x Geoffrey Kurland , x Steven H. Abman , x Timothy M. Hoffman , x Christopher L. Carroll , x Mary E. Cataletto , x Dmitry Tumin , x Eyal Oren , x Richard J. Martin , x Joyce Baker , x Gregory R. Porta , x Deborah Kaley , x Ann Gettys , and x Robin R. Deterding ; on behalf of the American Thoracic Society (...) altitude. Children 1 year old and younger living at 2,560 and 3,200 m had median Sp O 2 of 92% and 87%, respectively, according to two studies ( , ), whereas another study found that those living at altitudes of 1,371, 2,073, 2,393, 2,405, and 2,484 m had Sp O 2 ranges of 95–96.7%, 93.9–95.4%, 91.8–93.4%, 93.4–96.1%, and 93.7–96.2%, respectively ( ). Children older than 1 year old residing at an altitude of roughly 1,600 m had a median Sp O 2 of 95.4% (range, 93.1–96.9%) and a median nadir Sp O 2 of 86

2019 American Thoracic Society

128. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies

in establishing markers of venous congestion and impaired forward flow in CRS and are readily accessible clinical tools at the bedside. Echocardiography may help in diagnosing the congestive state by hemodynamic parameters, including CVP, systolic PA pressure, pulmonary capillary wedge pressure/left atrial pressure, and CO. Besides CVP, other useful echocardiographic measurements include lateral and septal wall longitudinal motion (E′) in relation to the mitral inflow velocity (E). The E/E′ ratio directly (...) the application of guideline-directed medical therapy. Currently, data on the efficacy of this device in patients with CRS or HF with advanced CKD are lacking. An implantable device (Optivol, Medtronic) has been used to assess transthoracic impedance as a measure of pulmonary fluid status. Direct measurements of intrathoracic impedance with an implanted device have been shown to have prognostic value in HF. However, a reduction in outpatient visits for HF symptoms or hospital admissions with the use of device

2019 American Heart Association

129. Management of Rotator Cuff Injuries

Guidelines and Appropriate Use Criteria in a User-Friendly Format, Please Visit the OrthoGuidelines Website at or by downloading the free app to your smartphone or tablet via the Apple and Google Play stores! View background material via the RC CPG eAppendix 1 View data summaries via the RC CPG eAppendix 2 4 Table of Contents Summary of recommendations 7 Management of Small to Medium Tears 7 Long Term Non-Operative Management 7 Operative Management 7 Acromioplasty & Rotator Cuff (...) treatment, reverse shoulder arthroplasty for unrepairable tears with glenohumeral joint arthritis can improve patient reported outcomes. Strength of Recommendation: Consensus DEVELOPMENT GROUP ROSTER Gregory A. Brown, MD, PhD – Oversight Chair American Academy of Orthopaedic Surgeons Stephen Weber, MD Co-Chair Arthroscopy Association of North America Jaskarndip Chahal, MD Co-Chair American Orthopaedic Society for Sports Medicine Shafic A. Sraj, MD American Academy of Orthopaedic Surgeons Jason M

2019 American Academy of Orthopaedic Surgeons

130. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease

, naltrexone, and enteral nutrition. Only human studies published in English were considered; fur- ther details regarding the search strategies used for preparing the initial consensus statements can be found in Supplementary Appendix 1. Additional focused (but non-systematic) searches were also performed up to the September 2016 consensus meeting. Review and Grading of Evidence Two non-voting methodologists (G.L., P .M.) used the GRADE approach 11 to assess the risk of bias (of individual studies (...) assessed symptomatically without endoscopy; therefore, the QoE was often downgraded for indirect outcomes, resulting in a low or very low QoE, making it difficult to approve strong recommendations in many cases. At the meeting, the group was unable to reach consensus on 5 of the initial statements (No recommendation A–E); thus, these statements were rejected. In addition, because of the ab- sence of evidence the group decided not to vote on 2 statements (No recommendation F and G) regarding strategies

2019 Canadian Association of Gastroenterology

131. Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Acute Headache

. Carpenter, MD 23 Deborah B. Diercks, MD, MSc 24 Seth R. Gemme, MD 25 Charles J. Gerardo, MD, MHS 26 Steven A. Godwin, MD 27 Sigrid A. Hahn, MD, MPH 28 Nicholas E. Harrison, MD (EMRA Representative 2017-2019) 29 Benjamin W. Hatten, MD, MPH 30 Jason S. Haukoos, MD, MSc (Methodologist) 31 Amy Kaji, MD, MPH, PhD (Methodologist) 32 Heemun Kwok, MD, MS (Methodologist) 33 Bruce M. Lo, MD, MBA, RDMS 34 Sharon E. Mace, MD 35 Devorah J. Nazarian, MD 36 Jean Proehl, RN, MN, CEN, CPEN, TCRN (ENA Representative 2015 (...) -2019) 37 Susan B. Promes, MD, MBA 38 Kaushal H. Shah, MD 39 Richard D. Shih, MD 40 Scott M. Silvers, MD 41 Michael D. Smith, MD, MBA 42 Molly E. W. Thiessen, MD 43 Christian A. Tomaszewski, MD, MS, MBA 44 Jonathan H. Valente, MD 45 Stephen P. Wall, MD, MSc, MAEd (Methodologist) 46 Stephen V. Cantrill, MD (Liaison with the ACEP Quality and Patient Safety Committee and the E-QUAL Steering 47 Committee) 48 Jon M. Hirshon, MD, PhD, MPH (Board Liaison 2016-2019) 49 Travis Schulz, MLS, AHIP, Staff

2019 American College of Emergency Physicians

132. Acute Treatment of Migraine in Children and Adolescents

Nicole Licking, DO, 8 Michael Sowell, MD, 9 M. Cristina Victorio, MD, 10 Elaine M. 7 Gersz, 11 Emily Leininger, 12 Heather Zanitsch, 13 Marcy Yonker, MD, 14 Kenneth Mack, MD, 8 PhD, 15 9 10 1. Departments of Pediatric and Neurology/Neurosurgery, McGill University, Montréal, 11 Canada 12 2. Department of Pediatrics (Neurology), Northwestern University Feinberg School of 13 Medicine, Chicago, IL 14 3. Department of Clinical Neurosciences, Psychiatry, Pediatrics and Community Health 15 Sciences, Cumming (...) subcommittee meetings where drafts of manuscripts were reviewed. All authors on the panel 14 were reimbursed by the AAN for expenses related to travel to in-person meetings. 15 16 17 18 19 5 1 2 3 4 5 6 DISCLOSURES 7 M. Oskoui has no relevant disclosures for this guideline. 8 Y. Holler-Managan serves on the editorial advisory board for Neurology Now. 9 T. Pringsheim has no relevant disclosures for this guideline. 10 S. Potrebic has received funding from the AAN for travel to biennial Guidelines

2019 American Academy of Neurology

133. Evaluation and Management of Obesity Hypoventilation Syndrome

ambulatory patients with OHS and coexistent severe obstructive sleep apnea, 4 ) patients hospitalized with respiratory failure and suspected of having OHS be discharged with noninvasive ventilation until they undergo outpatient diagnostic procedures and PAP titration in the sleep laboratory (ideally within 2–3 mo), and 5 ) patients with OHS use weight-loss interventions that produce sustained weight loss of 25% to 30% of body weight to achieve resolution of OHS (which is more likely to be obtained (...) with or without PAP treatment until the diagnosis of OHS is either confirmed or ruled out? Recommendation 4: We suggest that hospitalized patients with respiratory failure suspected of having OHS be started on NIV therapy before being discharged from the hospital, until they undergo outpatient workup and titration of PAP therapy in the sleep laboratory, ideally within the first 3 mo after hospital discharge ( conditional recommendation, very low level of certainty in the evidence ). Note: Discharging patients

Full Text available with Trip Pro

2019 American Thoracic Society

134. Recurrent Uncomplicated Urinary Tract Infections in Women

of urinary tract infections (UTIs) in the operative or procedural setting. In this document, the term UTI will refer to acute bacterial cystitis unless otherwise specified. This document seeks to establish guidance for the evaluation and management of patients with rUTIs to prevent inappropriate use of antibiotics, decrease the risk of antibiotic resistance, reduce adverse effects of antibiotic use, provide guidance on antibiotic and non-antibiotic strategies for prevention, and improve clinical outcomes (...) as at least two culture-proven symptomatic uncomplicated acute cystitis episodes in six months or three within one year in which symptom resolution occurred between culture- proven events. Microbial confirmation at the time of acute-onset urinary tract-associated symptoms and signs, which primarily include dysuria, urinary frequency and urgency, and new or worsening incontinence with or without gross hematuria, is a critical component to establish a diagnosis of rUTI. Continued documentation of cultures

2019 American Urological Association

135. Dacomitinib (Vizimpro) - non-small cell lung cancer (NSCLC)

, outpatient visits, cancer nurse hours as well as complete blood count, biochemistry, CT scans and chest x-rays for both the progression-free and post-progression states. The costs of treating treatment-related grade 3 and 4 adverse events were included and the cost of end-of-life care was applied when patients reached this state. The costs associated with second and third-line treatments were incorporated in the base case. For second line this was based on the proportion of participants who would likely (...) in advanced non-small cell lung cancer with EGFR mutations. Br J Cancer. 2017;116(5):568-74. Epub 01/20. 6. Park K, Tan E-H, O'Byrne K, Zhang L, Boyer M, Mok T, et al. Afatinib versus gefitinib as first- line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial. Lancet Oncology. 2016;17(5):577-89. 7. Paz-Ares L, Tan EH, O'Byrne K, Zhang L, Hirsh V, Boyer M, et al. Afatinib versus gefitinib in patients with EGFR

2019 Scottish Medicines Consortium

136. Safe Delivery of paediatric ENT surgery in the UK- a national strategy

):453-60. 27. Slovik Y, Tal A, Shapira Y, Tarasiuk A, Leiberman A. Complications of adenotonsillectomy in children with OSAS younger than 2 years of age. Int J Pediatr Otorhinolaryngol. 2003;67(8):847-51. 28. Kalantar N, Takehana CS, Shapiro NL. Outcomes of reduced postoperative stay following outpatient pediatric tonsillectomy. Int J Pediatr Otorhinolaryngol. 2006;70(12):2103-7. 29. Theilhaber M, Arachchi S, Armstrong DS, Davey MJ, Nixon GM. Routine post-operative intensive care is not necessary (...) DG, et al. A pilot study to identify pre- and peri-operative risk factors for airway complications following adenotonsillectomy for treatment of severe pediatric OSA. Int J Pediatr Otorhinolaryngol. 2011;75(11):1385-90. 33. McCormick ME, Sheyn A, Haupert M, Thomas R, Folbe AJ. Predicting complications after adenotonsillectomy in children 3 years old and younger. Int J Pediatr Otorhinolaryngol. 2011;75(11):1391-4. 34. Horwood L, Nguyen LH, Brown K, Paci P, Constantin E. African American ethnicity

2019 Association of Paediatric Anaesthetists of Great Britain and Ireland

137. Treatment of Diabetes in Older Adults

works by this author on: Mark E Molitch Northwestern University Feinberg School of Medicine, Chicago, Illinois Search for other works by this author on: M Hassan Murad Division of Preventive Medicine, Mayo Clinic, Rochester, Minnesota Search for other works by this author on: Alan J Sinclair King’s College, London, United Kingdom Search for other works by this author on: The Journal of Clinical Endocrinology & Metabolism , Volume 104, Issue 5, May 2019, Pages 1520–1574, Published: 23 March 2019 (...) Article history Accepted: 25 January 2019 Received: 25 January 2019 Citation Derek LeRoith, Geert Jan Biessels, Susan S Braithwaite, Felipe F Casanueva, Boris Draznin, Jeffrey B Halter, Irl B Hirsch, Marie E McDonnell, Mark E Molitch, M Hassan Murad, Alan J Sinclair, Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism , Volume 104, Issue 5, May 2019, Pages 1520–1574, Download citation file: © 2019 Oxford University

2019 The Endocrine Society

138. Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel Report

, USA. Tel: 317-274-9046; Fax: 317-274-9304; E-mail: . Search for other works by this author on: Daniel P Alford, MD, MPH Boston University School of Medicine, Boston, Massachusetts Search for other works by this author on: Charles Argoff, MD Albany Medical College, Albany, New York Search for other works by this author on: Bernard Canlas, MD Veterans Affairs Puget Sound Health Care System, Seattle, Washington Search for other works by this author on: Edward Covington, MD Cleveland Clinic, Cleveland (...) by this author on: Stefan G Kertesz, MD, MSc Birmingham Veterans Affairs Medical Center, Birmingham, Alabama Search for other works by this author on: Richard L Kravitz, MD, MSPH Department of Internal Medicine, University of California, Davis, California Search for other works by this author on: Erin E Krebs, MD, MPH Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota Search for other works by this author on: Steven P Stanos, Jr., DO Swedish Health System, Seattle, Washington Search

2019 American Academy of Pain Medicine

139. Registries for Evaluating Patient Outcomes: A User's Guide: Fourth Edition (Draft)

Key Stakeholders 34 2.4. Assess Feasibility 35 2.5. Build a Registry Team 37 2.6. Establish a Governance and Oversight Plan 39 2.7. Consider the Scope and Rigor Needed 39 2.7.1. Scope of Data 39 2.7.2. When Data Need To Be Available for Analysis 40 2.7.3. Scientific Rigor 40 2.8. Define the Core Data Set, Patient Outcomes, and Target Population 41 Registries for Evaluating Patient Outcomes – Fourth Edition DRAFT for Public Comment Only – NOT FOR CITATION Page 3 of 346 2.8.1. Core Data Set 41 2.8.2 (...) diseases in clinical practices but are not used for evaluating outcomes. Many of these other types of registries are included in the Registry of Patient Registries (RoPR) effort. RoPR is a central listing of patient registries established in 2012 by the Agency for Healthcare Research and Quality (AHRQ) in collaboration with the National Library of Medicine. 6 It is designed to improve transparency and reduce redundancy in registry-based Registries for Evaluating Patient Outcomes – Fourth Edition

2019 Effective Health Care Program (AHRQ)

140. Immediate postpartum long-acting reversible contraception for women at high risk for medical complications

to women desiring LARC. A randomized controlled trial evaluating an educational LARC script provided to womenduringpostpartumhospitalizationfoundhighinterest inLARCmethodsbutlowratesofactualLARCplacementat the 6-week postpartum visit. LARC use was equally low among womenwho receivedinpatient LARC education and those whodidnot(17.6vs.13.3%, P¼ .1). 65 Anotherstudy found that two-thirds of women who desired LARC did not receive it during outpatient appointments and used less effective contraceptive (...) Immediate postpartum long-acting reversible contraception for women at high risk for medical complications SocietyforMaternal-FetalMedicine(SMFM) ConsultSeries#48:Immediatepostpartum long-actingreversiblecontraceptionforwomen athighriskformedicalcomplications Society for Maternal-Fetal Medicine (SMFM); Laura K. Vricella, MD; Lori M. Gawron, MD, MPH; Judette M. Louis, MD, MPH The Society of Family Planning (SFP) endorses this document. The American College of Obstetricians and Gynecologists

2019 Society for Maternal-Fetal Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>